Publication | Open Access
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
421
Citations
30
References
2018
Year
PsychiatryMood SymptomMedicinePsychotropic MedicationDepressionPsychopharmacologyNeuropharmacologyDose-ranging TrialSocial SciencesMood DisordersDrug TherapyMental HealthPharmacologyIntravenous KetaminePsychopathologyTreatment-resistant Depression
| Year | Citations | |
|---|---|---|
Page 1
Page 1